These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23244434)

  • 1. Targeting epigenetics in nervous system disease.
    Zhang R; Lu J; Kong X; Jin L; Luo C
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):126-41. PubMed ID: 23244434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel etiological and therapeutic strategies for neurodiseases: epigenetic understanding of gene-environment interactions.
    Kubota T; Miyake K; Hirasawa T; Nagai K; Koide T
    J Pharmacol Sci; 2010; 113(1):3-8. PubMed ID: 20424390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.
    Franci G; Miceli M; Altucci L
    Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation.
    MacDonald JL; Roskams AJ
    Prog Neurobiol; 2009 Jul; 88(3):170-83. PubMed ID: 19554713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.
    Ricq EL; Hooker JM; Haggarty SJ
    Psychiatry Clin Neurosci; 2016 Dec; 70(12):536-550. PubMed ID: 27485392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.
    Urdinguio RG; Sanchez-Mut JV; Esteller M
    Lancet Neurol; 2009 Nov; 8(11):1056-72. PubMed ID: 19833297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
    Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of abnormal epigenetic patterns for human diseases.
    Santos-Rebouças CB; Pimentel MM
    Eur J Hum Genet; 2007 Jan; 15(1):10-7. PubMed ID: 17047674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.
    Falkenberg KJ; Johnstone RW
    Nat Rev Drug Discov; 2014 Sep; 13(9):673-91. PubMed ID: 25131830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Basis of Lead-Induced Neurological Disorders.
    Wang T; Zhang J; Xu Y
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone lysine methylation: an epigenetic modification?
    Blackledge NP; Klose RJ
    Epigenomics; 2010 Feb; 2(1):151-61. PubMed ID: 22122751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epigenetics for cancer therapy.
    Park JW; Han JW
    Arch Pharm Res; 2019 Feb; 42(2):159-170. PubMed ID: 30806885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
    Kobow K; Blümcke I
    Epilepsia; 2011 Jul; 52 Suppl 4():15-9. PubMed ID: 21732935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.
    Nguyen MP; Lee S; Lee YM
    Arch Pharm Res; 2013 Mar; 36(3):252-63. PubMed ID: 23440580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.